Result of AGM

RNS Number : 7924M
Bodycote PLC
25 May 2022
 

25 May 2022

 

Bodycote plc - Resolutions passed at the Annual General Meeting

 

Bodycote plc announces that all resolutions proposed at its Annual General Meeting held at 12 pm on 25 May 2022 were passed on a show of hands.

 

Details of proxy voting instructions, lodged prior to the Meeting are set out below:

 

Resolution

For

(number of votes)

 

Discretion

(number of votes)

Against

(number of votes)

Abstention

(number of votes)

 

Ordinary Resolutions

 

 

 

 

 

1. To receive the annual report

 

169,626,546

14,432

0

144,066

2. To declare a final dividend

 

169,770,776

13,393

13

862

 

Re-election of directors

 

 

 

 

 

3. To re-elect Mr D. Dayan

 

169,093,044

13,393

595,692

82,915

4. To re-elect Mr. S.C. Harris

 

169,630,359

13,393

58,653

82,639

5. To re-elect Ms E. Lindqvist

 

165,471,472

13,393

4,217,573

82,606

6. To re-elect Mr. I.B. Duncan

 

167,183,274

13,393

2,505,738

82,639

7. To re-elect Mr. D. Yates

 

168,900,276

13,393

788,736

82,639

8. To re-elect Mr. P. Larmon

 

167,589,817

13,393

2,099,195

82,639

9. To re-elect Ms. L. Chahbazi

 

167,602,761

13,393

2,085,411

83,479

10. To re-elect Mr. K. Boyd

167,615,144

13,393

2,073,868

82,639

11. To appoint the auditors

 

167,586,378

18,414

2,175,937

4,315

12. To authorise the directors to fix auditor's

  remuneration

 

169,752,642

13,393

12,186

6,823

13. To approve the report on remuneration

 

155,054,298

13,393

3,053,968

11,663,385

14. To approve the remuneration policy

 

120,988,831

13,393

36,980,280

11,802,612

15. To renew authority to allot shares

 

156,767,694

17,855

1,265,840

11,733,655

Special resolutions

 





16. To renew authority for disapplication of pre-

  emption rights in respect of 5% of issued share

  capital

 

169,391,029

17,855

367,726

8,434

17. To renew authority for disapplication of pre-

  emption rights for an additional 5% of issued share

  capital

165,043,538

17,855

4,715,217

8,434

18. To renew authority to buy own shares

 

167,047,182

17,855

2,609,688

110,319

19. To authorise general meetings 14 days' notice

 

167,261,568

20,578

2,500,913

1,985

 

The number of ordinary shares in issue on 25 May 2022 was 191,456,172.  A vote withheld is not a vote in law and is not counted in the calculation of the proportion of votes validly cast.

 

All resolutions presented to shareholders at today's Annual General Meeting were passed with a majority of votes. However, the Board recognises that some shareholders opposed resolution 14 (the approval of the remuneration policy).  While the Board is pleased that resolution 14 has received shareholder approval, it also acknowledges the views of the shareholders who opposed the resolution. The principal concern being that our remuneration policy now explicitly states that salary increases / pension contributions for Executive Directors are determined taking into account salary increases / pension contributions for the wider workforce in the country the executive director lives and / or works as well as the wider workforce across Western Europe including the UK. We contacted our major shareholders before the Annual General Meeting to confirm that this is not a change in how we remunerate our Executive Directors and rather clarifies existing practice, and to offer to discuss their views on this matter.  We will continue to engage with our shareholders to ensure views are fully understood and report back within six months.

 

A copy of the Resolutions passed as Special Business at the Annual General Meeting is being submitted to the UK Listing Authority and will shortly be available for inspection at the FCA Electronic Submission System , which is situated at https://data.fca.org.uk/#/nsm/nationalstoragemechanism

 

 

U. Ball, Group Company Secretary, Bodycote plc

Tel:  +44 (0)1625 505300

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
RAGFELFLLELFBBK

Companies

Bodycote (BOY)
UK 100

Latest directors dealings